Detailed price information for Angiodynamics Inc (ANGO-Q) from The Globe and Mail including charting and trades.
One of the most durable, and often underappreciated, drivers of earnings quality among MedTech companies is a favorable ...
AngioDynamics shows how product mix shifts toward higher-margin Med Tech platforms are quietly reshaping earnings power ...
Trowbridge announced, “We are raising components of our full year fiscal 2026 guidance. We now expect net sales to be in the range of $312 million to $314 million raised from our previously issued ...
AngioDynamics Inc. (ANGO) reported its second-quarter fiscal year 2026 earnings on January 6, showcasing a positive performance that exceeded market expectations. The company reported earnings per ...
Stevi Allen just wanted her body back. The 38-year-old, admittedly, hadn't been 'taking care' of herself. Her figure had changed after giving birth to her son in 2019, then the pandemic hit, and, as a ...
Ended fiscal 2026 second quarter with $41.6 million in cash and cash equivalents, ahead of the Company’s expectations, continues to expect to be cash flow positive for the full year FY 2026 Received ...
“When we talk about recurrence of melanoma, we actually worry more about what we cannot see, what's on the inside,” Dr. Justine V. Cohen of the Dana-Farber Cancer Institute told CURE®. Patients with ...
This growth was led by the Auryon peripheral atherectomy platform, which saw sales rise 18.6% to $16.3 million, while NanoKnife sales jumped 22.2% to $7.3 million. "We delivered an excellent second ...
The excessive deficit procedure aims to ensure that all member states maintain low government debt or reduce high debt to sustainable levels. On this page: What is the excessive deficit procedure?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback